← Back to screener

Inspire Medical Systems, Inc. INSP

Rank #1903 · NYSE · $2.0B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
39.2
P/E
-92.8
P/B
3.96
ROE
-4.3%
Op. Margin
-6.4%
Debt Ratio
24%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -92.8x, P/B 3.96x. Ranks in the top 64% of the universe.

Profitability ★☆☆☆☆
Weak

ROE -4.3%. Ranks in the top 74% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 24%. Ranks in the top 14% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★★
Excellent

Revenue growth of 53.2% year over year. Ranks in the top 7% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2018$0.0B$-0.0B$-0.0B$-0.0B-105.0-2081
2019$0.0B$-0.0B$-0.0B$-0.0B-56.0-546
2020$0.1B$-0.0B$-0.0B$0.0B-40.33121
2021$0.1B$-0.0B$-0.0B$0.2B-42.531
2022$0.1B$-0.1B$-0.1B$0.1B-48.747
2023$0.2B$-0.0B$-0.0B$0.2B-17.130
2024$0.4B$-0.0B$-0.0B$0.2B-11.746
2025$0.6B$-0.0B$-0.0B$0.5B-6.424

← See the full screener